Imiquimod in the treatment of extensive recurrent lentigo maligna.

Abstract

We report the case of a 70-year-old white male with an extensive recurrence of lentigo maligna in a skin-transplanted region. He was treated with imiquimod 5% cream topically applied 5 times a week for a total duration of 9 months. Clinically and histologically, a complete clearing of the lesion was observed after treatment. Topical treatment with imiquimod seems to be effective and safe in lentigo maligna.

• Authors: Anne Kamin, Thomas K Eigentler, Peter Radny, Jürgen Bauer, Benjamin Weide, Claus Garbe
• Journal: Journal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 52 Issue 2 Suppl 1 Pg. 51-2 (Feb 2005) ISSN: 1097-6787 [Electronic] United States
• PMID: 15692515 (Publication Type: Case Reports, Journal Article)

Chemical References

• Aminoquinolines
• Antineoplastic Agents
• Imiquimod

Topics

• Administration, Cutaneous
• Aged
• Aminoquinolines (therapeutic use)
• Antineoplastic Agents (therapeutic use)
• Facial Neoplasms (drug therapy, pathology)
• Humans
• Hutchinson's Melanotic Freckle (drug therapy, pathology)
• Imiquimod
• Male
• Neoplasm Recurrence, Local (drug therapy)
• Skin Neoplasms (drug therapy, pathology)